IFNA1 and systemic lupus erythematosus: For example, a whole blood RT-PCR classifier to classify SLE patients with predominant IFN, plasmablast, neutrophil or erythropoiesis signatures may be warranted before embarking on targeted therapy against certain cytokines or immune cells [16,87].